[Development of a novel targeted therapy for human glioblastoma].
Ishiuchi
Shogo
S
Department of Neurosurgery, School of Medical School, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005909:Glioblastoma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D016202:N-Methylaspartate / Q000502:physiology; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D017470:Receptors, Glutamate / Q000145:classification / Q000502:physiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000627:therapeutic use
D018691:Excitatory Amino Acid Antagonists; C409466:NR1 NMDA receptor; D018091:Receptors, AMPA; D017470:Receptors, Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D016202:N-Methylaspartate